Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RELATLIMAB vs REMIMAZOLAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RELATLIMAB vs REMIMAZOLAM: Safety Overview

Metric RELATLIMAB REMIMAZOLAM
Total FAERS Reports 177 137
Deaths Reported 29 3
Death Rate 16.4% 2.2%
Hospitalizations 145 24
Average Patient Age 64.5 yrs 60.4 yrs
% Female Patients 34.6% 41.5%
FDA Approval Date N/A Oct 6, 2020
Manufacturer N/A Acacia Pharma, Ltd.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription